mohd izzuan Shares of Assertio ( NASDAQ: ASRT ) closed 8% higher Monday after the company refuted allegations leveled by activist investor Buxton Helmsley over its accounting practices and approval of its drug Rolvedon. Last Friday, Buxton Helmsley announced it had “inverted its long equity position.
Back to Health Page
